Is Johnson & Johnson Stock A Better Pick Over AbbVie?
AbbVie trades at a higher valuation of 5.5x trailing revenues, compared to 4.6x for JNJ.
Source: forbes.com
Stay updated with breaking news from Abbv Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie trades at a higher valuation of 5.5x trailing revenues, compared to 4.6x for JNJ.
SAN FRANCISCO, April 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges AbbVie Inc. (NYSE: ABBV) investors who suffered significant losses to submit your...